Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Crosslink Therapeutics reported raising $5.5 Million in an initial SEC Form D filing, from an offering of $5.5 Million

PRIVATEOct 20, 2026

Amount Raised

$5.5 Million

$5.5 Million sold, per SEC Form D (first sale Oct 8, 2026)

Round Type

Venture

BostonHealth Care

Company Information

Company

Crosslink Therapeutics

Location

349-351 NEWBURY STREET

Boston, Massachusetts, United States

About

Crosslink Therapeutics is developing a groundbreaking approach to cancer treatment by targeting a key hallmark of solid tumors: elevated extracellular adenosine triphosphate (eATP). Leveraging this tumor-specific trait, Crosslink has engineered a modular biologic domain that enables therapeutics to assemble selectively within the tumor microenvironment. This innovative technology can be integrated across a wide range of therapeutic modalities to enhance tumor targeting and efficacy. Currently, Crosslink is focused on advancing first-in-class and best-in-class applications in antibody-drug conjugates (ADCs) and radioligand therapies, aiming to significantly improve precision and outcomes in cancer care.

Fundz sees it the moment Crosslink Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Crosslink Therapeutics's next move

See what Strategic adds

Crosslink Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.